Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia
Journal of Neuroimaging · 2025
DOI: 10.1111/jon.70014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroimaging, 2025. Verfasst von Eun Hye Jeong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Bundang Jesaeng General Hospital, Seongnam-si, Republic of Korea. Hauptthemen laut MEDLINE: Parkinson Disease, Levodopa, Dyskinesia, Drug-Induced, Serotonin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Background and Purpose We investigated the relationship between serotonergic and dopaminergic specific binding transporter ratios (SBRs) over 4 years in Parkinson's disease (PD) patients. We assessed serotonergic innervation's potential compensatory role for dopaminergic denervation, association with PD symptoms, and involvement in the development of levodopa‐induced dyskinesia (LID).
Methods
SBRs of the midbrain and striatum were evaluated from [I‐123] N ‐ω‐fluoropropyl‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)nortropane SPECT images at baseline and after 4 years. Correlations between SBRs and PD symptoms were analyzed, alongside interval changes.
Results
Study included 177 PD patients (110 males, 67 females; mean age 61.0 ± 9.0 years). Significant worsening was observed in Hoehn and Yahr staging and Movement Disorder Society‐Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) Part II and III scores over 4 years ( p < 0.05, p < 0.001, and p < 0.001, respectively). SBRs of the caudate, putamen, and midbrain declined significantly ( p < 0.001). Midbrain and striatal SBRs correlated significantly at both baseline and 4‐year follow‐up ( p < 0.0001). Striatal SBRs correlated significantly with MDS‐UPDRS II and III scores at both time points, while midbrain SBRs correlated with changes in MDS‐UPDRS III scores over the 4 years ( p < 0.01). Putamen and midbrain SBRs at 4 years were significantly lower in patients who developed LID compared to those who did not ( p < 0.05).
Conclusion
The study demonstrates correlations between midbrain and putamen SBRs and MDS‐UPDRS scores over 4 years in PD patients. Midbrain serotonin dysfunction may contribute to the development of LID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Bundang Jesaeng General Hospital, Seongnam-si, Republic of Korea.
- Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
- College of Medicine, Seoul National University, Seoul, Republic of Korea.
ORCID-Profile: Yoo Sung Song
Zitieren
APA
Jeong, E. H., Lee, J. Y., & Song, Y. S. (2025). Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia. Journal of Neuroimaging. https://doi.org/10.1111/jon.70014
Vancouver
Jeong EH, Lee JY, Song YS. Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia. Journal of Neuroimaging. 2025. doi:10.1111/jon.70014
BibTeX
@article{Jeong2025,
author = {Jeong, Eun Hye and Lee, Jae Yong and Song, Yoo Sung},
title = {Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia},
journal = {Journal of Neuroimaging},
year = {2025},
doi = {10.1111/jon.70014}
}
EUVIMED